Argo Biopharma doses first participant in Phase I trial of factor XI targeting siRNA therapy

Acadia Pharmaceuticals announces receipt of FDA Fast Track designation for remlifanserin to treat Alzheimer's disease psychosis

Almirall advances Ebglyss paediatric regulatory filing in Europe

Sareum completes dosing in Phase 2-enabling toxicology programme for SDC-1801

GSK seeks European approval for single-dose Bexsero booster in older children and adults

Evaxion to present three-year cancer vaccine data at ESMO Congress 2026

Ananda Pharma doses first patient in MRX1 clinical trial of patients with chemotherapy induced peripheral neuropathy

Aqemia and Sanofi expand drug discovery collaboration with new research target

Camurus' FDA accepts CAM2029 NDA resubmission for acromegaly, sets December decision date

Raidium introduces AI-powered oncology imaging workflow for US cancer centres

World Health Organization approves 'codabakalner' as International Nonproprietary Name for Spinogenix's SPG601

Circio and Avenue Biosciences launch research collaboration to improve protein secretion for gene therapy

Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones

Lakewood-Amedex Biotherapeutics reports positive Nu-3 Gel preclinical safety data for upcoming Phase 2a trial

MAXONA Pharmaceuticals' Phase 2 clinical trial IND application for MAX-001 cleared by US FDA